1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
SD BioSensor, Inc

SD BioSensor, Inc

137310.KS
SD BioSensor, IncKR flagKorea Exchange
6,400.00
KRW
-220.00
- -
765.56BMarket Cap

Total Valuation

SD BioSensor, Inc carries a market capitalization of 765.56B, placing it among publicly traded companies globally. Its enterprise value stands at 733.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap765.56B
Enterprise Value733.97B

Share Statistics

SD BioSensor, Inc currently has 119.62M shares outstanding.

Shares Outstanding119.62M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

SD BioSensor, Inc trades at a trailing price-to-earnings ratio of 12.90. The price-to-sales ratio is 1.27, and the price-to-book ratio stands at 0.64.

PE Ratio12.90
PS Ratio1.27
PB Ratio0.64
P/TBV Ratio0.86
P/FCF Ratio2.15
P/OCF Ratio2.47

Enterprise Valuation

EV / Sales1.02
EV / EBITDAN/A
EV / EBITN/A
EV / FCF1.53

Financial Position

SD BioSensor, Inc maintains a current ratio of 5.07, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.04, indicating elevated leverage, while an interest coverage ratio of -0.77 demonstrates limited ability to service its debt obligations.

Current Ratio5.07
Quick Ratio2.63
Debt / Equity13.04
Debt / EBITDA-3.97
Interest Coverage-0.77

Financial Efficiency

Return on Equity (ROE)-27.37
Return on Assets (ROA)-13.87
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.61

Taxes

Income Tax-403.09B
Effective Tax RateN/A

Stock Price Statistics

SD BioSensor, Inc's stock has declined approximately -36.12774% over the past 52 weeks. The 50-day moving average sits at 7,444.00, while the 200-day moving average is 8,581.85.

Beta (5Y)N/A
52-Week Price Change-36.12774%
50-Day Moving Average7,444.00
200-Day Moving Average8,581.85
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, SD BioSensor, Inc generated 718.78B in revenue and converted that into -470.73B in net income, yielding earnings per share of -3,945.43. EBITDA reached -77.94B, while operating income came in at -77.94B.

Revenue718.78B
Gross Profit332.86B
Operating Income-77.94B
Pretax Income-875.35B
Net Income-470.73B
EBITDA-77.94B
EBIT-77.94B
Earnings Per Share (EPS)-3,945.43

Balance Sheet

SD BioSensor, Inc holds 497.60B in cash and equivalents against 309.61B in total debt, resulting in a net debt position of 109.35B. Total book value stands at 1.44T, with working capital of 770.95B providing operational flexibility.

Cash & Cash Equivalents497.60B
Total Debt309.61B
Net Debt109.35B
Equity (Book Value)1.44T
Book Value Per Share11,989.22
Working Capital770.95B

Cash Flow

SD BioSensor, Inc produced 370.08B in operating cash flow over the past twelve months. After subtracting -54.95B in capital expenditures, free cash flow totaled 315.14B - equivalent to 2,632.77 per share.

Operating Cash Flow370.08B
Capital Expenditures-54.95B
Free Cash Flow315.14B
FCF Per Share2,632.77

Margins

SD BioSensor, Inc operates with a gross margin of 46.31, reflecting its pricing power and cost economics. The operating margin of -10.84 and net profit margin of -65.49 provide insight into operational efficiency.

Gross Margin46.31
Operating Margin-10.84
Pretax Margin-121.78
Profit Margin-65.49
EBITDA Margin-10.84

Dividends & Yields

The company's payout ratio of -5.10 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share201.87
Dividend YieldN/A
Payout Ratio-5.10
Shareholder Yield44.91
FCF Yield46.42

Scores

SD BioSensor, Inc posts an Altman Z-Score of 2.98, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.98